Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
Clinical trial NCT01875237 · TERMINATED
Trial details
- NCT number
- NCT01875237
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-27
- Primary completion
- 2017-03-07
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.